The Supreme Court on Friday mentioned that actor Rhea Chakraborty’s case against Sushant Singh Rajput’s sister Priyanka Singh is not going to be cancelled. Chakraborty had accused Priyanka of arranging a pretend prescription to assist Sushant entry banned medicine. The CBI will now take over the case and investigate the matter because the SC had earlier dominated that every one FIRs associated to Sushant’s loss of life can be investigated by the central investigation company.

Rhea Chakraborty who’s being investigated by a number of central businesses after Sushant Singh Rajput’s household accused her of getting a job within the actor’s loss of life filed a criticism against Rajput’s sisters Priyanka and Mitu Singh. The sisters have been accused of forgery and violation of the NDPS (Narcotic Drugs and Psychotropic Substances) Act based mostly on the criticism by Chakraborty.

Chakraborty had filed a criticism based mostly on Whatsapp texts exchanged between Sushant and Priyanka Singh on June 8, six days earlier than his demise. According to the chat, Priyanka had suggested her brother to take three medicines- Librium, Mexito and Lonazep. These are prescribed for despair and anxiousness however not purchased over-the-counter and require prescription.

On February 15, the Bombay High Court mentioned that the investigation against Priyanka Singh would proceed whereas cancelling the case against Mitu Singh. On Friday, Priyanka’s lawyer argued within the SC that there was no proof of Sushant consuming the mentioned drugs. She additionally mentioned in her petition that the physician she consulted was certified to prescribe the medication and thru teleconsultation.

ALSO READ:  Sushant Singh Rajput case: NCB files 12,000 page chargesheet

BOLLYWOOD NEWS

Catch us for contemporary Bollywood News, New Bollywood Movies replace, Box office collection, New Movies Release , Bollywood News Hindi, Entertainment News, Bollywood News Today & upcoming movies 2020 and keep up to date with newest hindi films solely on Reply99.